As of Aug 30
| +0.26 / +0.70%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +60.13% increase from the last price of 37.47.
The current consensus among 1 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.